How Much Upside Can NVDA Stock’s Growth Deliver?

At $196.51, NVIDIA (NVDA) looks set up for roughly 56% upside over the next three years under a conservative scenario. That is a move large enough to justify digging into where it comes from. Revenue compounding does the work, but the multiple takes a meaningful cut along the way. Here is the operational reality the math is built on:

The company that defined the GPU market now tells customers they do not buy GPUs, but build entire AI factories. This pivot is aimed at a massive new market the company has never addressed before. It fundamentally changes the growth profile.

This strategic shift adds a new growth engine to an already dominant one. The company’s Data Center revenue is compounding at a staggering rate. This new business could steepen the revenue trajectory further.

*LTM: Last Twelve Months

How The Math Gets There

Three projections drive the upside number. Revenue compounds at 30% annually over three years, a further step down from the LTM 71% pace, reflecting the deceleration already visible in the trailing numbers. Net margin eases from 63% to 60% as today’s LTM reverts partway toward the 3-year average of 52%. And the multiple has work to do that is not in the company’s favor. NVDA’s P/E already sits at 29.9x, below its 3-year average of 54.2x. The scenario trims it further to 22.4x, because a slower forward growth rate no longer supports even today’s multiple.

Put those three together and earnings move from $159.6B to roughly $331.5B, a 108% jump. Apply the lower multiple to that base and the stock lands near $306.13, only 56% above today. The multiple takes its cut before the earnings work reaches the share price.

Can NVDA Pull That Off?

The new VeraCPU is the key catalyst not yet in the run-rate. Management claims VeraCPU opens a brand new $200 billion TAM. More concretely, they see nearly $20 billion in total CPU revenue this year.

And what could break it?

The bear case is buried in the discussion of the next product cycle. Asked to compare the upcoming VeraRubin ramp to the current one, management conceded it is hard to say which will be faster. They concluded it was a little early to say, leaving the next growth wave an open question.

If You’re Buying NVDA At Today’s Price

You are paying for steady compounding, not a re-rating and not a margin miracle. The bet is that revenue keeps moving at roughly the projected pace; if it doesn’t, the math has nowhere else to turn.

The near-term VeraCPU revenue is concrete, making uncertainty around the future VeraRubin ramp a manageable risk for now.

Should You Invest In NVIDIA?

For a different read on NVDA, see our recent piece Beyond The GPU: What Could Drive NVIDIA Stock Higher From Here?

A careful 3-year case on a single name is still a concentrated bet, as historical volatility across past market crises shows. Investors who build analyses like this on individual positions often want the same framework running across a diversified book, partly for discipline, partly because even the cleanest single-stock thesis can break for reasons the math does not capture.

If it is exposure to technology as a whole you want rather than this one name, a technology ETF like VGT covers that single sector. Going broader than any one sector, to a quality-first mix across the whole market, is where the portfolio below comes in.

The Trefis High Quality (HQ) Portfolio combines analytical rigor with a forward-looking view across 30 stocks, with a consistent selection framework and a sizing and re-balancing discipline designed to deliver upside without the single-name risk you just read through here.

By selecting 30 high-conviction stocks, the HQ strategy has historically outpaced a benchmark that combines the three major indices – the S&P 500, S&P Mid-cap, and Russell 2000.